NasdaqGS - Nasdaq Real Time Price USD

Surgery Partners, Inc. (SGRY)

23.42 -1.05 (-4.29%)
At close: April 18 at 4:00 PM EDT
22.64 -0.78 (-3.33%)
After hours: April 18 at 6:28 PM EDT
Loading Chart for SGRY
DELL
  • Previous Close 24.47
  • Open 24.47
  • Bid 23.38 x 100
  • Ask 23.46 x 200
  • Day's Range 23.19 - 24.47
  • 52 Week Range 22.05 - 45.79
  • Volume 1,818,735
  • Avg. Volume 898,938
  • Market Cap (intraday) 2.965B
  • Beta (5Y Monthly) 2.74
  • PE Ratio (TTM) --
  • EPS (TTM) -0.09
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 42.36

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

www.surgerypartners.com

10,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SGRY

Performance Overview: SGRY

Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SGRY
26.79%
S&P 500
5.06%

1-Year Return

SGRY
36.51%
S&P 500
20.71%

3-Year Return

SGRY
47.00%
S&P 500
19.73%

5-Year Return

SGRY
137.77%
S&P 500
72.77%

Compare To: SGRY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGRY

Valuation Measures

As of 4/18/2024
  • Market Cap

    2.97B

  • Enterprise Value

    5.83B

  • Trailing P/E

    --

  • Forward P/E

    21.10

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.07

  • Price/Book (mrq)

    1.49

  • Enterprise Value/Revenue

    2.13

  • Enterprise Value/EBITDA

    13.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.43%

  • Return on Assets (ttm)

    3.82%

  • Return on Equity (ttm)

    4.07%

  • Revenue (ttm)

    2.74B

  • Net Income Avi to Common (ttm)

    -11.9M

  • Diluted EPS (ttm)

    -0.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    195.9M

  • Total Debt/Equity (mrq)

    91.60%

  • Levered Free Cash Flow (ttm)

    142.69M

Research Analysis: SGRY

Analyst Price Targets

35.00
42.36 Average
23.42 Current
50.00 High
 

Fair Value

Near Fair Value
% Return
23.42 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch